$AXIM
AXIM BIOTECHNOLOGIES, INC.

2013 Q4 Form 10-Q Financial Statement

#000151495513000030 Filed on November 18, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $10.83K
YoY Change 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $190.00
YoY Change -110.75%
Net Earnings / Revenue 1.75%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 33.00M shares 33.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $127.00 $1.235K $19.13K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.127K $4.735K $39.13K
YoY Change -92.01% -55.61%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $53.70K $86.20K $93.70K
YoY Change -42.69% 90.56%
TOTAL ASSETS
Total Short-Term Assets $3.127K $4.735K $39.13K
Total Long-Term Assets $53.70K $86.20K $93.70K
Total Assets $56.82K $90.93K $132.8K
YoY Change -57.22% -3.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $150.7K $141.9K $137.5K
YoY Change 9.61% 8.2%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $150.7K $141.9K $137.5K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$66.05K -$19.80K
YoY Change 304.54%
Common Stock $3.300K $3.300K $3.300K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$93.92K -$50.95K -$4.698K
YoY Change
Total Liabilities & Shareholders Equity $56.82K $90.93K $132.8K
YoY Change -57.22% -3.26%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income $190.00
YoY Change -110.75%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001514946
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33000000 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
AXIM INTERNATIONAL INC.
CY2013Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
46726 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32570 USD
CY2013Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
11000 USD
CY2012Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
20000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11700 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11700 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7500 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7500 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3750 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13804 USD
CY2013Q3 us-gaap Assets
Assets
90931 USD
CY2012Q4 us-gaap Assets
Assets
132824 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
4735 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
39128 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1235 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19128 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7507 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23138 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-17893 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-15631 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1235 USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
195000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
195000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33000000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33000000 shares
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
3300 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3300 USD
CY2013Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
50000 USD
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
50000 USD
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21667 USD
CY2013Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
42407 USD
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
30985 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13804 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6304 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
100000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
100000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
86196 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93696 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10643 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67921 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12600 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43351 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
141051 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14156 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18110 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
46726 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-21667 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-32500 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7500 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7500 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-9000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-30000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
11000 USD
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
450 USD
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
1350 USD
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
2750 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90931 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132824 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
141883 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
137522 USD
us-gaap Liquidity Disclosure Going Concern Note
LiquidityDisclosureGoingConcernNote
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%; WIDTH: 100%"> <!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><strong><u style="BACKGROUND: white; color: black; font-family: times new roman; FONT-SIZE: 10pt"> NOTE 3.&nbsp;&nbsp;&nbsp; GOING CONCERN</u></strong></p> <p style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"><strong style="color: black; font-family: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: none"> &nbsp;</strong></p> <p style="BACKGROUND: white; color: black; font-family: times new roman; FONT-SIZE: 10pt; MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: justify"> The Company&#39;s financial statements have been presented assuming that the Company will continue as a going concern.&nbsp;&nbsp;As shown in the financial statements, the Company has negative working capital, has an accumulated deficit of $ 66,052, and presently does not have the resources to accomplish its objectives during the next twelve months. These conditions raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments related to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue in operation.</p> <!--EndFragment--></div> </div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11422 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24510 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105407 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29315 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9859 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4172 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
190 USD
us-gaap Net Income Loss
NetIncomeLoss
-46254 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-1767 USD
us-gaap Net Income Loss
NetIncomeLoss
-10851 USD
us-gaap Net Income Loss
NetIncomeLoss
-66052 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
100000 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
100 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
50000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11422 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24510 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
42407 USD
CY2013Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66052 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19798 USD
CY2013Q3 us-gaap Revenues
Revenues
10833 USD
us-gaap Revenues
Revenues
21667 USD
CY2012Q3 us-gaap Revenues
Revenues
10833 USD
us-gaap Revenues
Revenues
32500 USD
us-gaap Revenues
Revenues
74999 USD
CY2013Q3 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
2750 USD
CY2012Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
2300 USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-2100 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-50952 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-4698 USD
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33000000 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33000000 shares

Files In Submission

Name View Source Status
0001514955-13-000030-index-headers.html Edgar Link pending
0001514955-13-000030-index.html Edgar Link pending
0001514955-13-000030.txt Edgar Link pending
0001514955-13-000030-xbrl.zip Edgar Link pending
aximsept302013ex311.htm Edgar Link pending
aximsept302013ex321.htm Edgar Link pending
aximsept302013final.htm Edgar Link pending
fil-20130930.xml Edgar Link completed
fil-20130930.xsd Edgar Link pending
fil-20130930_cal.xml Edgar Link unprocessable
fil-20130930_def.xml Edgar Link unprocessable
fil-20130930_lab.xml Edgar Link unprocessable
fil-20130930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending